Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs

Human Molecular Genetics

Volumn 24, Issue 6, 2015, Pages 1513-1527

  Suzuki, Hiroaki ^a   Shibagaki, Yoshio ^b   Hattori, Seisuke ^b   Matsuoka, Masaaki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; TAR DNA BINDING PROTEIN; DNA BINDING PROTEIN; HNRNP A2; NUCLEAR PROTEIN; POLDIP3 PROTEIN, HUMAN; RNA BINDING PROTEIN; TDP-43 PROTEIN, HUMAN;

ARTICLE; CELL DEATH; DIMERIZATION; DNA BINDING; GENE OVEREXPRESSION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RNA BINDING; RNA SPLICING; ANIMAL; CELL NUCLEUS; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MOUSE; NERVE CELL; PROTEIN TRANSPORT;

ANIMALS; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN U; HUMANS; MICE; NEURONS; NUCLEAR PROTEINS; PROTEIN TRANSPORT; RNA SPLICING; RNA-BINDING PROTEINS;

EID: 84936070824     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu563     Document Type: Article

References (50)

1. Ferraiuolo, L., Kirby, J., Grierson, A.J., Sendtner, M. and Shaw, P.J. (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol., 7, 616-630.
2. Renton, A.E., Chiò, A. and Traynor, B.J. (2014) State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci., 17, 17-23.
3. Rademakers, R., Neumann, M. and Mackenzie, I.R. (2012) Advances in understanding the molecular basis of frontotemporal dementia. Nat. Rev. Neurol., 8, 423-434.
4. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133.
5. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602-611.
6. Janssens, J. and Van Broeckhoven, C. (2013) Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum. Mol. Genet., 22, 77-87.
7. Ling, S.C., Polymenidou, M. and Cleveland, D.W. (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron, 79, 416-438.
8. Buratti, E. and Baralle, F.E. (2010) The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol., 7, 420-429.
9. Ayala, Y.M., Zago, P., D'Ambrogio, A., Xu, Y.F., Petrucelli, L., Buratti, E. and Baralle, F.E. (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci., 121, 3778-3785.
10. Lee, E.B., Lee, V.M. and Trojanowski, J.Q. (2011) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci., 13, 38-50.
11. Xu, Z.S. (2012) Does a loss of TDP-43 function cause neurodegeneration?. Mol. Neurodegener., 7, 27.
12. Swarup, V., Phaneuf, D., Dupré, N., Petri, S., Strong, M., Kriz, J. and Julien, J.P. (2011) Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways. J. Exp. Med., 208, 2429-2447.
13. Kasai, T., Tokuda, T., Ishigami, N., Sasayama, H., Foulds, P., Mitchell, D.J., Mann, D.M., Allsop, D. and Nakagawa, M. (2009) Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta. Neuropathol., 117, 55-62.
14. Suzuki, M., Mikami, H., Watanabe, T., Yamano, T., Yamazaki, T., Nomura, M., Yasui, K., Ishikawa, H. and Ono, S. (2010) Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta. Neurol. Scand., 122, 367-372.
15. Verstraete, E., Kuiperij, H.B., van Blitterswijk, M.M., Veldink, J. H., Schelhaas, H.J., van den Berg, L.H. and Verbeek, M.M. (2012) TDP-43 plasma levels are higher in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler., 13, 446-451.
16. Mishra, M., Paunesku, T., Woloschak, G.E., Siddique, T., Zhu, L.J., Lin, S., Greco, K. and Bigio, E.H. (2007) Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta. Neuropathol., 114, 81-94.
17. Johnson, B.S., McCaffery, J.M., Lindquist, S. and Gitler, A.D. (2008) A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA., 105, 6439-6444.
18. Liu, Y.C., Chiang, P.M. and Tsai, K.J. (2013) Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int. J. Mol. Sci., 14, 20079-20111.
19. Austin, J.A., Wright, G.S., Watanabe, S., Grossmann, J.G., Antonyuk, S.V., Yamanaka, K. and Hasnain, S.S. (2014) Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc. Natl Acad. Sci. USA., 111, 4309-4314.
20. Watanabe, S., Kaneko, K. and Yamanaka, K. (2013) Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J. Biol. Chem., 288, 3641-3654.
21. Ling, S.C., Albuquerque, C.P., Han, J.S., Lagier-Tourenne, C., Tokunaga, S., Zhou, H. and Cleveland, D.W. (2010) ALSassociated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl Acad. Sci. USA., 107, 13318-13323.
22. Suzuki, H., Lee, K. and Matsuoka, M. (2011) TDP-43-induced death is associated with altered regulation of BIM and BclxL and attenuated by caspase-mediated TDP-43 cleavage. J. Biol. Chem., 286, 13171-13183.
23. Suzuki, H. and Matsuoka, M. (2012) TDP-43 toxicity is mediated by the unfolded protein response-unrelated induction of C/EBP homologous protein expression. J. Neurosci. Res., 90, 641-647.
24. Suzuki, H. and Matsuoka, M. (2013) The JNK/c-Jun signaling axis contributes to the TDP-43-induced cell death. Mol. Cell Biochem., 372, 241-248.
25. Winton, M.J., Igaz, L.M., Wong, M.M., Kwong, L.K., Trojanowski, J.Q. and Lee, V.M. (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem., 283, 13302-13309.
26. Makkerh, J.P., Dingwall, C. and Laskey, R.A. (1996) Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids. Curr. Biol., 6, 1025-1027.
27. Kuo, P.H., Doudeva, L.G., Wang, Y.T., Shen, C.K. and Yuan, H.S. (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res., 37, 1799-1808.
28. Buratti, E. and Baralle, F.E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem., 276, 36337-36343.
29. Zhang, Y.J., Caulfield, T., Xu, Y.F., Gendron, T.F., Hubbard, J., Stetler, C., Sasaguri, H., Whitelaw, E.C., Cai, S., Lee, W.C. et al. (2013) The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum. Mol. Genet., 22, 3112-3122.
30. Han, S.P., Tang, Y.H. and Smith, R. (2010) Functional diversity of the hnRNPs: past, present and perspectives. Biochem. J., 430, 379-392.
31. Shiga, A., Ishihara, T., Miyashita, A., Kuwabara, M., Kato, T., Watanabe, N., Yamahira, A., Kondo, C., Yokoseki, A., Takahashi, M. et al. (2012) Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One, 7, e43120.
32. Fiesel, F.C., Weber, S.S., Supper, J., Zell, A. and Kahle, P.J. (2012) TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res., 40, 2668-2682.
33. Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y.M. and Baralle, F.E. (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem., 280, 37572-37584.
34. Kim, H.J., Kim, N.C., Wang, Y.D., Scarborough, E.A., Moore, J., Diaz, Z., MacLea, K.S., Freibaum, B., Li, S., Molliex, A. et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature, 495, 467-473.
35. Arnold, E.S., Ling, S.C., Huelga, S.C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H.B., McAlonis-Downes, M., Platoshyn, O., Parone, P.A. et al. (2013) ALS-linked TDP-43 mutations produce aberrant RNA splicing and adultonset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. USA., 110, E736-E745.
36. Xu, Y.F., Prudencio, M., Hubbard, J.M., Tong, J., Whitelaw, E.C., Jansen-West, K., Stetler, C., Cao, X., Song, J. and Zhang, Y.J. (2013) The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43. PLoS One, 8, e69864.
37. Yamashita, M., Nonaka, T., Hirai, S., Miwa, A., Okado, H., Arai, T., Hosokawa, M., Akiyama, H. and Hasegawa, M. (2014) Distinct pathways leading to TDP-43-induced cellular dysfunctions. Hum. Mol. Genet., 23, 4345-4356.
38. Ash, P.E., Zhang, Y.J., Roberts, C.M., Saldi, T., Hutter, H., Buratti, E., Petrucelli, L. and Link, C.D. (2010) Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum. Mol. Genet., 19, 3206-3218.
39. Liu, R., Yang, G., Nonaka, T., Arai, T., Jia, W. and Cynader, M.S. (2013) Reducing TDP-43 aggregation does not prevent its cytotoxicity. Acta. Neuropathol. Commun., 1, 49.
40. Vanden Broeck, L., Callaerts, P. and Dermaut, B. (2014) TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?. Trends Mol. Med., 20, 66-71.
41. Iguchi, Y., Katsuno, M., Niwa, J., Yamada, S., Sone, J., Waza, M., Adachi, H., Tanaka, F., Nagata, K., Arimura, N. et al. (2009) TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. J. Biol. Chem., 284, 22059-22066.
42. Voigt, A., Herholz, D., Fiesel, F.C., Kaur, K., Müller, D., Karsten, P., Weber, S.S., Kahle, P.J., Marquardt, T. and Schulz, J.B. (2010) TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS One, 5, e12247.
43. Ihara, R., Matsukawa, K., Nagata, Y., Kunugi, H., Tsuji, S., Chihara, T., Kuranaga, E., Miura, M., Wakabayashi, T., Hashimoto, T. et al. (2013) RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Hum. Mol. Genet., 22, 4474-4484.
44. Freibaum, B.D., Chitta, R.K., High, A.A. and Taylor, J.P. (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res., 9, 1104-1120.
45. Pinkus, J.L., Amato, A.A., Taylor, J.P. and Greenberg, S.A. (2014) Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis. Neuromuscul. Disord., 24, 611-616.
46. Tollervey, J.R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., König, J., Hortobágyi, T., Nishimura, A.L., Zupunski, V. et al. (2011) Characterizing the RNA targets and positiondependent splicing regulation by TDP-43. Nat. Neurosci., 14, 452-458.
47. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Huelga, S. C., Moran, J., Liang, T.Y., Ling, S.C., Sun, E., Wancewicz, E., Mazur, C. et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci., 14, 459-468.
48. Lagier-Tourenne, C., Polymenidou, M., Hutt, K.R., Vu, A.Q., Baughn, M., Huelga, S.C., Clutario, K.M., Ling, S.C., Liang, T. Y., Mazur, C. et al. (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci., 15, 1488-1497.
49. Highley, J.R., Kirby, J., Jansweijer, J.A., Webb, P.S., Hewamadduma, C.A., Heath, P.R., Higginbottom, A., Raman, R., Ferraiuolo, L., Cooper-Knock, J. et al. (2014) Loss of nuclear TDP-43 in ALS causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurons. Neuropathol. Appl. Neurobiol., 40, 670-685.
50. Nonaka, T., Arai, T., Buratti, E., Baralle, F.E., Akiyama, H. and Hasegawa, M. (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett., 583, 394-400.